A prospective, multicenter, randomized controlled, non-inferiority clinical trial to evaluate the safety and efficacy of the LineMatrix® bioengineered vascular graft as arteriovenous fistulas for hemodialysis

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2025
This article has no abstract
Epistemonikos ID: 3944817174dc2604693b89faf9915b15be65dce7
First added on: Sep 06, 2025